ETF·NYSE
iShares U.S. Medical Devices ETF (IHI)
- Net assets
- $3.45B
- Expense ratio
- 0.37%
- Yield
- 0.51%
- 52-week range
- $47.37 $64.71
The short version
Where IHI stands today, in four lines, and what CleaRank Financial AI makes of it.
IHI at a glance
iShares U.S. Medical Devices ETF (IHI): Buy, 70/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 50-day but below its 200-day moving average ($53.24 and $53.98).
- Fund Expense ratio 0.37%, $3.4B in net assets, -14.4% total return over 1 year.
Figures as of October 16, 2026.
CleaRank Financial AI
The iShares U.S. Medical Devices ETF (IHI) is currently trading at $53.76, showing a bullish technical posture.
The fund's strategy focuses on U.S. companies involved in the manufacturing and distribution of medical equipment, a segment of the healthcare sector that supports diagnosis, treatment, and patient care. Despite a recent year-to-date return of -17.35%, the ETF's price is above its 20-day EMA and 50-day SMA, suggesting positive short-to-medium term momentum. The sector allocation is 100.00% in Healthcare, indicating a concentrated exposure to this industry.
Only on CleaRank
Figures we compute ourselves from IHI's own price history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
1/4Price above its 50-day average ›
The price of $53.76 is 1.0% above the 50-day simple moving average of $53.24.Price above its 200-day average ›
The price is 0.4% below the 200-day simple moving average of $53.98.50-day average above the 200-day ›
The 50-day average ($53.24) is 1.4% below the 200-day average ($53.98), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 37% of its 52-week range, between $47.37 and $64.71.
IHI share price
Pick a period: each tab shows how far IHI has moved over it, to the last close.
Today's trading
Where IHI sits inside today's range and its 52-week range.
Fund facts and valuation
What the fund holds, what it costs and how it is valued.
Fund checks
2/5Expense ratio at or below 0.20% ›
The fund charges 0.37% a year, $37.00 on a $10,000 holding.Over $1B in net assets ›
Net assets total $3.4B.No sector above 35% of the fund ›
The largest sector, Healthcare, makes up 100.0% of the fund.Pays a distribution ›
The distribution yield is 0.51%.Positive return over one year ›
The fund family reports a one-year total return of -14.45%.
IHI Fund Facts
iShares U.S. Medical Devices ETF is an exchange-traded fund that seeks to track the Dow Jones U.S. Select Medical Equipment Index, giving investors broad exposure to U.S. companies involved in the medical devices sector. The fund focuses on manufacturers and distributors of medical equipment used in diagnostics, imaging, patient monitoring, surgical procedures, and therapeutic care, including products such as pacemakers, prosthetics, MRI scanners, X-ray machines, and related non-disposable devices.
Sector weights
Trailing total returns
| Period | IHI |
|---|---|
| YTD | -17.35% |
| 1 month | -6.75% |
| 3 months | 3.72% |
| 1 year | -14.45% |
| 3 years | 2.26% |
| 5 years | -3.56% |
| 10 years | 8.20% |
As of Oct 16, 2026, IHI has an expense ratio of 0.37%, $3.45B in net assets and a distribution yield of 0.51%.
Fund reference data as of Oct 16, 2026. Expense ratio and net assets are reported by the fund; returns are total returns and can differ from price change.
Key statistics
The headline figures for IHI.
What the numbers say
CleaRank Financial AI's reading of IHI's holdings, performance and risks.
The iShares U.S. Medical Devices ETF (IHI) is managed by iShares, with an expense ratio of 0.37% and net assets totaling $3.45 billion.
The fund's strategy is to track the Dow Jones U.S. Select Medical Equipment Index, providing concentrated exposure to U.S. companies in the medical devices sector. This sector is integral to the healthcare system, supporting diagnostic and therapeutic care. The fund's portfolio is heavily weighted towards stocks, representing 99.86% of its asset allocation, with 100.00% dedicated to the Healthcare sector.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 61.9, showing bullish momentum without being overbought.RSI above 50 ›
An RSI of 61.9 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank AI analysis of IHI
The score, the reasoning behind it, and what could move the price next.
IHI is currently trading above its 20-day EMA at $52.28 and its 50-day SMA at $53.24, indicating upward price momentum.
However, the price is below its 200-day SMA at $53.98, suggesting a potential resistance level. The 14-day RSI is at 61.9, which is in the bullish territory, indicating strong momentum without being overbought. The Stochastic indicator at 80.59 suggests the ETF is approaching overbought conditions, which could signal a potential pause or pullback in the near term. The 50-day SMA at $53.24 is acting as support, while the 200-day SMA at $53.98 presents a resistance level.
- Monitor the 200-day SMA at $53.98 as a key resistance level for IHI.
Technical indicators
Momentum and trend for IHI, from its daily closes.
As of October 16, 2026, with IHI at $53.76, its 14-day RSI is 61.9 (showing bullish momentum without being overbought), its 50-day simple moving average is $53.24 and its 200-day is $53.98.
Calculated by CleaRank on daily closes as of October 16, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What IHI moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 16, 2026, IHI's 1-year correlation of daily returns is +0.54 with S&P 500 (SPY), +0.39 with Nasdaq 100 (QQQ), +0.07 with Bitcoin (BTC) and +0.08 with gold (XAU).
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
IHI trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from IHI's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much IHI tends to move, against the market and on its own.
The long record
IHI's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 1.21% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 32.9%, from September 2021 to October 2023; the price is still 17.7% below that peak.Most 1-year holds ended higher ›
76% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $23,987, against $42,525 in the S&P 500 (SPY).
IHI Drawdowns & Recovery
As of October 16, 2026, IHI's worst peak-to-trough fall over the last 10 years with dividends reinvested was -32.9% (September 2021 to October 2023); it is still 17.7% below that peak, and 76% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into IHI in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: IHI trailed the S&P 500 over this period: $23,987 against $42,525.
A $10,000 investment in IHI in October 2016 would be worth about $23,987 today with dividends reinvested, compared with about $42,525 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to IHI, and which have not.
Strongest month, January: an average of +4.00%, up in 8 of 10 years.
Weakest month, March: an average of -2.13%, up in 4 of 10 years.
This month, October: has averaged -0.22%, up in 6 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, IHI's strongest calendar month has been January (average +4.00%, up in 8 of 10 years) and its weakest March (average -2.13%, up in 4 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in IHI, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in IHI today could grow to about $20,186 by 2036 in the base case, with a 90th-percentile outcome near $45,665 and a 10th-percentile outcome around $8,923. The simulation models price only; at today's 0.51% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
IHI 2030 Scenarios (Monte Carlo)
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $71.20 for IHI by 2030 in the base case, from $53.76 today (1.3x over 4 years). The 10th-percentile path ends near $42.49. These are outcomes of a Monte Carlo simulation run on IHI's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $44.55 | $57.67 | $74.66 | |
| 2028 | $42.95 | $61.87 | $89.13 | |
| 2029 | $42.44 | $66.37 | $104 | |
| 2030 | $42.49 | $71.20 | $119 | |
| 2031 | $42.88 | $76.38 | $136 |
Method: a lognormal simulation of IHI's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Questions people ask
Answered from the figures on this page, as of October 16, 2026.